362703-48-8 Usage
General Description
Ethyl 1-Boc-piperidine-2-carboxylate is a chemical compound with the molecular formula C12H21NO4. It is used in scientific research and development, specifically in pharmaceutical and medicinal chemistry. It serves as a critical intermediate in the production of several complex molecules for drug synthesis. This chemical compound belongs to the family of piperidines, which are heterocyclic organic compounds that contain a nitrogen atom in a six-membered ring. Its safety, handling procedures, and potential toxicity are subject to various international regulations and safety standards.
Check Digit Verification of cas no
The CAS Registry Mumber 362703-48-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,2,7,0 and 3 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 362703-48:
(8*3)+(7*6)+(6*2)+(5*7)+(4*0)+(3*3)+(2*4)+(1*8)=138
138 % 10 = 8
So 362703-48-8 is a valid CAS Registry Number.
InChI:InChI=1/C13H23NO4/c1-5-17-11(15)10-8-6-7-9-14(10)12(16)18-13(2,3)4/h10H,5-9H2,1-4H3
362703-48-8Relevant articles and documents
The Baylis-Hillman reaction with chiral α-amino aldehydes under racemization-free conditions
Coelho, Fernando,Diaz, Gaspar,Abella, Carlos A. M.,Almeida, Wanda P.
, p. 435 - 439 (2007/10/03)
The Baylis-Hillman reaction with chiral α-amino aldehydes has been revisited. The reaction carried out under the influence of ultrasound avoids the aldehyde racemization almost completely, providing useful chiral substrates which can be used as starting materials for the synthesis of natural products. To demonstrate the synthetic applicability of these adducts, the easy preparation of a bicyclic lactam with an indolizidinic skeleton was accomplished. Georg Thieme Verlag Stuttgart.
Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha
-
Page/Page column 48, (2010/11/30)
The present application describes novel β-amino acid derivatives of formula I: or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, X, Z, Ua, Xa, Ya, Za, R1, R2, R3
